Yu Tony's Form 4 filing
GENELUX Corp (GNLX) · filed Jul 8, 2024
- Accession no.
- 0001415889-24-019343
- Filed
- Jul 8, 2024
- Trade date
- Feb 19-Jun 24, 2024
- Filing delay
- 140 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $14.5K. It was filed 140 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yu TonyCIK 0001937482 | Officer (VP, Clinical Trial Operations) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2024 | Common Stock | AGrant or awardAcquired | +3,661 | $0.00 | $0 | 6,161 | Direct | |
| Mar 14, 2024 | Common Stock | AGrant or awardAcquired | +11,557 | $0.00 | $0 | 17,718 | Direct | |
| Jun 24, 2024 | Common Stock | SSaleDisposed | −6,849 | $2.12 | −$14,519.88 | 10,869 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.